Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 323

1.

Pathobiology of CD30+ cutaneous T-cell lymphomas.

Kadin ME.

J Cutan Pathol. 2006 Feb;33 Suppl 1:10-7. Review.

PMID:
16412208
2.

MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Müller B, Pfaltz M.

Br J Dermatol. 2008 Jun;158(6):1280-7. doi: 10.1111/j.1365-2133.2008.08566.x. Epub 2008 Apr 10.

PMID:
18410414
3.

Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.

Kempf W, Levi E, Kamarashev J, Kutzner H, Pfeifer W, Petrogiannis-Haliotis T, Burg G, Kadin ME.

J Cutan Pathol. 2002 May;29(5):295-300.

PMID:
12100631
5.

Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.

Clarke LE, Bayerl MG, Bruggeman RD, Mauger D, Ioffreda MD, Abou-Elella A, Helm KF.

Am J Surg Pathol. 2005 Apr;29(4):452-9.

PMID:
15767797
6.

Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.

Greisser J, Palmedo G, Sander C, Kutzner H, Kazakov DV, Roos M, Burg G, Kempf W.

J Cutan Pathol. 2006 Nov;33(11):711-5.

PMID:
17083688
7.

Need for an improved molecular/genetic classification for CD30+ lymphomas involving the skin.

Droc C, Cualing HD, Kadin ME.

Cancer Control. 2007 Apr;14(2):124-32. Review.

9.

Apoptosis in CD30-positive lymphoproliferative disorders of the skin.

Greisser J, Doebbeling U, Roos M, Mueller B, Schmid M, Burg G, Kadin ME, Kempf W.

Exp Dermatol. 2005 May;14(5):380-5.

PMID:
15854132
10.

Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.

Boulland ML, Wechsler J, Bagot M, Pulford K, Kanavaros P, Gaulard P.

Histopathology. 2000 Feb;36(2):136-44.

PMID:
10672058
11.

Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin.

Steinhoff M, Hummel M, Anagnostopoulos I, Kaudewitz P, Seitz V, Assaf C, Sander C, Stein H.

Blood. 2002 Jul 15;100(2):578-84.

12.
13.

Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.

Benner MF, Jansen PM, Meijer CJ, Willemze R.

Br J Dermatol. 2009 Jul;161(1):121-7. doi: 10.1111/j.1365-2133.2009.09147.x. Epub 2009 Apr 16.

PMID:
19416236
14.

CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas: A clue to the pathophysiology of clinical regression.

Mori M, Manuelli C, Pimpinelli N, Mavilia C, Maggi E, Santucci M, Bianchi B, Cappugi P, Giannotti B, Kadin ME.

Blood. 1999 Nov 1;94(9):3077-83.

15.

Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders.

Liang X, Smoller BR, Golitz LE.

J Cutan Pathol. 2002 Sep;29(8):459-64.

PMID:
12207739
16.

Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas.

Mao X, Orchard G, Russell-Jones R, Whittaker S.

Br J Dermatol. 2007 Nov;157(5):914-21. Epub 2007 Aug 24.

PMID:
17725669
17.

Common clonal T-cell origin in a patient with T-prolymphocytic leukaemia and associated cutaneous T-cell lymphomas.

Assaf C, Hummel M, Dippel E, Schwartz S, Geilen CC, Harder L, Siebert R, Steinhoff M, Klemke CD, Thiel E, Goerdt S, Stein H, Orfanos CE.

Br J Haematol. 2003 Feb;120(3):488-91.

PMID:
12580966
18.

Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.

De Souza A, Tinguely M, Pfaltz M, Burghart DR, Kempf W.

J Cutan Pathol. 2014 Dec;41(12):901-6. doi: 10.1111/cup.12411. Epub 2014 Nov 25.

PMID:
25353265
19.

Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.

Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R.

Arch Dermatol. 2001 Jul;137(7):901-5.

PMID:
11453809
20.

Supplemental Content

Support Center